Advertisement
Advertisement
RPID
Rapid Micro Biosystems, Inc. Class A Common Stock
4.17
USDSponsored
-0.19
-4.36%
Mar 05, 15:58 UTC -5
Closed
After-Market
4.04
-0.13
-3.21%
RPID Earnings Reports
Positive Surprise Ratio
RPID beat 8 of 18 last estimates.
44%
Next Report
Next Week
Date of Next Report
Mar 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$11.58M
/-$0.22
Implied change from Q3 25 (Revenue/ EPS)
+47.70%
/-15.38%
Implied change from Q4 24 (Revenue/ EPS)
+40.87%
/--
Rapid Micro Biosystems, Inc. Class A Common Stock earnings per share and revenue
On Nov 07, 2025, RPID reported earnings of -0.26 USD per share (EPS) for Q3 25, missing the estimate of -0.24 USD, resulting in a -4.04% surprise. Revenue reached 7.84 million, compared to an expected 7.91 million, with a -0.85% difference. The market reacted with a +12.73% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 11.58 million USD, implying an decrease of -15.38% EPS, and increase of 47.70% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Opko Health Inc.
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+42.28%
Integra LifeSciences Holdings
Report Date
Feb 26, 2026 For Q4 25
Estimate
$0.81
Actual
$0.83
Surprise
+1.68%
Neuropace, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.08
Surprise
+48.22%
OrthoPediatrics Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.43
Surprise
-25.36%
Delcath Systems Inc
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.05
Surprise
+20.51%
Sight Sciences, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.08
Surprise
+43.66%
908 Devices Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.05
Surprise
+29.97%
Anteris Technologies Global Corp. Common Stock
Report Date
Feb 26, 2026 For Q4 25
Estimate
-$0.59
Actual
-$0.74
Surprise
-24.18%
Treace Medical Concepts, Inc. Common Stock
Report Date
Feb 27, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.15
Surprise
+1.96%
Masimo Corporation
Report Date
Feb 26, 2026 For Q4 25
Estimate
$1.50
Actual
-Surprise
-
FAQ
What were Rapid Micro Biosystems, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Rapid Micro Biosystems, Inc. Class A Common Stock reported EPS of -$0.26, missing estimates by -4.04%, and revenue of $7.84M, -0.85% below expectations.
How did the market react to Rapid Micro Biosystems, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 12.73%, changed from $2.75 before the earnings release to $3.10 the day after.
When is Rapid Micro Biosystems, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Mar 12, 2026.
What are the forecasts for Rapid Micro Biosystems, Inc. Class A Common Stock's next earnings report?
Based on 6
analysts, Rapid Micro Biosystems, Inc. Class A Common Stock is expected to report EPS of -$0.22 and revenue of $11.58M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement